Biogen expects Leqembi and new rare disease and depression treatments to help offset revenue lost from multiple sclerosis products.
Related Posts
S&P 5,000: Wall Street finally knows where the ‘Trump put’ is
The latest turn in the global trade war saga gave investors insight into where the elusive “Trump put” is.
Musk whips opposition to Trump tax plan: ‘KILL the BILL’
Musk’s reaction to Trump’s bill likely comes in part because it cuts an EV tax credit that helps Tesla, a source familiar with the matter […]
Treasury delays deadline for small businesses to file new form to avoid risk of fines for noncompliance
The Treasury delayed a Jan. 1 deadline to file a new “beneficial ownership information” report to Jan. 13 following a recent court order.